Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115112 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Md Saqline Mostaq und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, University of Louisiana at Monroe, Monroe, LA 71201, USA. Hauptthemen laut MEDLINE: Glucosyltransferases, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Sphingolipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Edward Via College of Osteopathic Medicine, NIGMS NIH HHS.
Abstract (Originalsprache)
Emergent cancer drug resistance and further metastasis can mainly be attributed to altered expression levels and functional activities of multiple genes of cancer cells under chemotherapy. In response to challenge with anticancer drugs, enhanced ceramide glycosylation catalyzed by glucosylceramide synthase (GCS) confers drug resistance and enrichment with cancer stem cells. p53 mutations, which gain function in tumor progression, are prevalently extant in ovarian cancers. Via integrated gene expression assessments, we characterized GCS-responsive genes in ovarian cancer cells treated with dactinomycin. NCI/ADR-RES cells dominantly expressed a p53 mutant (7 aa deleted in exon-5) and displayed anti-apoptosis; however, silencing GCS expression rendered these cells sensitive to dactinomycin-induced apoptosis. Microarray analyses of NCI/ADR-RES and its GCS transfected sublines found that elevated GCS expression or ceramide glycosylation was associated with altered expression of 41 genes, notably coding for ABCB1, FGF2, ALDH1A3, apolipoprotein E, laminin 2, chemokine ligands, and IL6, with cellular resistance to induced apoptosis and enrichment with cancer stem cells, promoting cancer progression. These findings were further corroborated through integrated genomic analyses of ovarian cancer from The Cancer Genome Atlas (TCGA) and cancer resistance to platinum-based chemotherapy. Altogether, our present study indicates that altered ceramide glycosylation can modulate expression of these GCS-responsive genes and alter cancer cell attributes under chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Pharmaceutical and Toxicological Sciences, University of Louisiana at Monroe, Monroe, LA 71201, USA.
- Department of Biomedical Affairs and Research, Edward Via College of Osteopathic Medicine, Monroe, LA 71203, USA.
- Department of Biomedical Sciences and Pathobiology, Virginia Tech, VA-MD Regional College of Veterinary Medicine, Blacksburg, VA 24060, USA.
- Department of Pharmacology, Toxicology and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA.
- Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA.
ORCID-Profile: Md Saqline Mostaq, Yunfeng Zhao, Yong-Yu Liu
Förderung
- NCI NIH HHS
- Edward Via College of Osteopathic Medicine
- NIGMS NIH HHS
- National Institutes of Health
- Delta Collaborative Research Program
Zitieren
APA
Mostaq, M. S., Kang, L., Patwardhan, G. A., Zhao, Y., Shi, R., & Liu, Y. Y. (2025). Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115112
Vancouver
Mostaq MS, Kang L, Patwardhan GA, Zhao Y, Shi R, Liu YY. Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115112
BibTeX
@article{Mostaq2025,
author = {Mostaq, Md Saqline and Kang, Lin and Patwardhan, Gauri A and Zhao, Yunfeng and Shi, Runhua and Liu, Yong-Yu},
title = {Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115112}
}
EUVIMED